F+FreeMedSite USMLELearn with clinical reasoning
SEPARATE VIVA EXTENSION

ADP-P2Y12 platelet signaling and antiplatelet therapy

Follow-up oral questions and concise, clinically defensible model answers. Your MCQ remains open in its original tab.

← Return to original MCQ
EXAMINER FOLLOW-UP 1

Which platelet receptor mediates fibrinogen bridging during aggregation?

Integrin αIIbβ3, commonly called glycoprotein IIb/IIIa.

EXAMINER FOLLOW-UP 2

What is aspirin's antiplatelet target?

Irreversible cyclooxygenase-1 inhibition in platelets.

EXAMINER FOLLOW-UP 3

What platelet receptor is targeted by ticagrelor?

P2Y12, through reversible direct antagonism.